Mycobacterium tuberculosis, drug resistance

Scheme information

Service

External quality assessment

Scheme

Mycobacterium tuberculosis, drug resistance

Service provider

Labquality

Accreditation

Not accredited

Status

Pilot in 2022, in production 2023

Target

Laboratories

Coverage

Analytical phase

Rounds

4

Distributions

Globally

Coordinator

Jaana Paakkanen

Expert

Products

5230 / Mycobacterium tuberculosis, drug resistance

Samples: 2 simulated samples, 1 mL

Type: Physical sample

Examinations: Mycobacterium tuberculosis nucleic acid detection, rifampicin susceptibility and isoniazid susceptibility

Additional information:

Search other products Show similar products

Pin It on Pinterest

Share This